The outcomes supported that all materials and methods used in this study were valid, and can be applied for CTCs via CK19 mRNA detection in canine blood of CMT patients, and for gene expression in canine mammary neoplastic tissues using ddPCR. This evidence concerns the gene KRT19 and Charcot-Marie-Tooth disease.